Stock listing
OTC:AONC American Oncology Network, Inc. Stock
Follow American Oncology Network, Inc. into a list and get an email when it puts out news.
Share price · OTC:AONC
$22.03 USD -0.97 (-4.2%)
Close on Oct 30, 2026
- Day range
- $22.03 – $22.03 USDOct 30, 2026
- Volume
- 101 sharesOct 30, 2026
- Market cap
- $644.3M USDAt the close on Oct 30, 2026 · price × 29.25M shares outstanding
- 52-week range
- $0.0004 – $25.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $17,907 USDMedian day 0 shares · 35 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026

Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:AONC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $22.03 | -0.97 | -4.2% | $22.03 | $22.03 | $22.03 | 101 | |
| $23.00 | +2.20 | +10.6% | $20.50 | $23.00 | $20.50 | 2,137 | |
| $20.80 | -1.21 | -5.5% | $20.80 | $20.80 | $20.80 | 466 | |
| $22.01 | +0.01 | 0.0% | $22.93 | $22.93 | $22.01 | 800 | |
| $22.00 | +1.00 | +4.8% | $21.00 | $25.00 | $21.00 | 6,400 | |
| $21.00 | +13.00 | +162.5% | $8.00 | $21.03 | $8.00 | 40,200 | |
| $8.00 | -3.00 | -27.3% | $8.00 | $8.00 | $8.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | +1.00 | +10.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 100 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | -1.00 | -9.1% | $10.00 | $10.00 | $10.00 | 400 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 100 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | 0.00 | 0.0% | $11.00 | $11.00 | $11.00 | 0 | |
| $11.00 | +1.01 | +10.1% | $11.00 | $11.00 | $11.00 | 100 | |
| $9.99 | 0.00 | 0.0% | $9.99 | $9.99 | $9.99 | 0 | |
| $9.99 | 0.00 | 0.0% | $9.99 | $9.99 | $9.99 | 0 | |
| $9.99 | 0.00 | 0.0% | $9.99 | $9.99 | $0.0010 | 1,200 | |
| $9.99 | 0.00 | 0.0% | $9.99 | $9.99 | $9.99 | 0 | |
| $9.99 | -0.01 | -0.1% | $9.99 | $9.99 | $9.99 | 100 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | -3.00 | -23.1% | $10.00 | $10.00 | $10.00 | 100 | |
| $13.00 | 0.00 | 0.0% | $13.00 | $13.00 | $13.00 | 0 | |
| $13.00 | 0.00 | 0.0% | $13.00 | $13.00 | $13.00 | 0 | |
| $13.00 | +3.01 | +30.1% | $13.00 | $13.00 | $13.00 | 100 | |
| $9.99 | -2.01 | -16.8% | $9.99 | $9.99 | $9.99 | 100 | |
| $12.00 | 0.00 | 0.0% | $12.00 | $12.00 | $12.00 | 0 | |
| $12.00 | +0.88 | +7.9% | $12.00 | $12.00 | $12.00 | 100 | |
| $11.12 | 0.00 | 0.0% | $11.12 | $11.12 | $11.12 | 0 | |
| $11.12 | 0.00 | 0.0% | $11.12 | $11.12 | $11.12 | 0 | |
| $11.12 | 0.00 | 0.0% | $11.12 | $11.12 | $11.12 | 0 | |
| $11.12 | -1.08 | -8.9% | $11.12 | $11.12 | $11.12 | 100 | |
| $12.20 | 0.00 | 0.0% | $12.20 | $12.20 | $12.20 | 0 | |
| $12.20 | +2.21 | +22.1% | $12.20 | $12.20 | $12.20 | 200 | |
| $9.99 | 0.00 | 0.0% | $9.99 | $9.99 | $9.99 | 0 | |
| $9.99 | -0.01 | -0.1% | $9.99 | $9.99 | $7.00 | 1,000 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 100 | |
| $10.00 | 0.00 | 0.0% | $10.00 | $10.00 | $10.00 | 0 | |
| $10.00 | -2.00 | -16.7% | $10.00 | $10.00 | $10.00 | 100 |
- Ticker
- OTC:AONC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- OTC
- Currency
- USD
American Oncology Network, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- Calls
- 3 calls with a replay · 3 with a transcript · latest May 16, 2024
- Decks
- 2 decks · latest Sep 29, 2023
Valuation
price Oct 30, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- -0.24
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| American Oncology Network, Inc. · OTC:AONC | US$644.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.24 |
| Phreesia, Inc. · NYSE:PHR | US$708.2M | US$634.7M | 67.8× | 1.3× | 12.8× | 1.9× | 2.1% | 0.0× | 0.42 |
| Jinxin Fertility Group Ltd. · HKEX:1951 | US$692.4M | US$1.02B | n/a | 2.6× | 12.6× | 0.5× | −36.9% | 0.3× | n/a |
| Xunfei Healthcare Technology Co., Ltd. · HKEX:2506 | US$681.9M | US$664.6M | n/a | 4.8× | n/a | 5.3× | −7.1% | 0.1× | n/a |
| Fulgent Genetics, Inc. · NASDAQ:FLGT | US$673.9M | US$381.6M | n/a | 1.2× | n/a | 0.7× | −27.5% | 0.0× | 0.99 |
| Bright Eye Hospital Group Co., Ltd. Class A · SZSE:301239 | US$669.8M | US$635.8M | 60.6× | 1.4× | n/a | 2.1× | 2.4% | 0.1× | n/a |
| Shanghai Runda Medical Technology Co., Ltd. Class A · SSE:603108 | US$661.9M | US$589.8M | n/a | 0.6× | n/a | 1.2× | −8.6% | 0.1× | n/a |
| PT Metro Healthcare Indonesia Tbk · IDX:CARE | US$648.2M | US$680.5M | 1,733× | 21.8× | n/a | 3.9× | 1.2% | 0.5× | n/a |
| Wuxi Commercial Mansion Grand Orient Co., Ltd. Class A · SSE:600327 | US$640.0M | US$570.9M | n/a | 1.5× | n/a | 1.6× | −11.5% | 0.0× | n/a |
| Ramkhamhaeng Hospital Public Co. Ltd. · SET:RAM | US$625.4M | US$905.1M | 7.7× | 1.5× | 8.4× | 0.9× | 13.5% | 0.5× | n/a |
| WELL Health Technologies Corp. · TSX:WELL | US$606.6M | US$1.09B | n/a | 1.0× | 7.9× | 1.1× | −8.3% | 1.1× | 1.08 |
| Median of the others | US$665.8M | US$650.2M | 64.2× | 1.4× | 10.5× | 1.4× | −7.7% | 0.1× | 0.99 |
Team and board
Officers
| Officer | Role |
|---|---|
| Todd Schonherz | CHIEF EXECUTIVE OFFICER |
| David Afshar | CHIEF FINANCIAL & OPERATING OFFICER |
| Ella S. Friedman | PRESIDENT NETWORK OPERATIONS |
| Charles Charlie Goddard | GENERAL COUNSEL |
| Puneeth Indurlal | EXECUTIVE VICE PRESIDENT OF STRATEGIC OPERATIONS & ENTERPRISE SOLUTIONS |
| Steve Swart | EXECUTIVE VICE PRESIDENT PRACTICE OPERATIONS |
| Alti Rahman | CHIEF STRATEGY & INNOVATION OFFICER |
| Anthony Belott | CHIEF DEVELOPMENT OFFICER |
| James Gilmore | CHIEF PHARMACY & CLINICAL SERVICES OFFICER |
| Joe Verschleiser | CHIEF GROWTH & PERFORMANCE OFFICER |
| Karen Pilley | CHIEF REVENUE CYCLE OFFICER |
| Kristin Matisziw | CHIEF COMPLIANCE & RISK OFFICER |
| Mark Moch | CHIEF INFORMATION OFFICER |
| Stephen Fred Divers | CHIEF MEDICAL OFFICER |
| Tena Messer | CHIEF CLINICAL OFFICER |
| Terri Casey | CHIEF HUMAN RESOURCES OFFICER |
Board
| Director | Role |
|---|---|
| Antonio Moran | BOARD MEMBER |
| Asit Jha | BOARD MEMBER |
| Bradley M. Fluegel | BOARD MEMBER |
| Bradley T. Sumrall | BOARD MEMBER |
| Christopher Chay | BOARD MEMBER |
| Daniel Spitz | BOARD MEMBER |
| Daniel T. Milton | BOARD MEMBER |
| Farn Chan | BOARD MEMBER |
| James Stith | BOARD MEMBER |
| Jay Sidloski | BOARD MEMBER |
| Jeanna L. Knoble | BOARD MEMBER |
| Jiantao Ding | BOARD MEMBER |
| Jose Alemar | BOARD MEMBER |
| Joseph Z. Ye | BOARD MEMBER |
| Luis T. Campos | BOARD MEMBER |
| Martin Palmeri | BOARD MEMBER |
| Michael J. Castine | BOARD MEMBER |
| Praveen Kollipara | BOARD MEMBER |
| Raja S. Mehdi | BOARD MEMBER |
| Ralph V. Boccia | BOARD MEMBER |
| Ram S. Trehan | BOARD MEMBER |
| Rangappa Rajendra | BOARD MEMBER |
| Ravi Sarin | BOARD MEMBER |
| Sakeer Hussain | BOARD MEMBER |
| Sam Mikhail | BOARD MEMBER |
| Sreekanth C. Reddy | BOARD MEMBER |
| Stephen Fred Divers | CHIEF MEDICAL OFFICER |
| Taral Patel | BOARD MEMBER |
| Todd Schonherz | CHIEF EXECUTIVE OFFICER |
| William Bill J. Valle | BOARD MEMBER |
Events
Calls
| Call | When | Status |
|---|---|---|
| American Oncology Network (OTC:AONC) Q1 2024 Earnings Call | Thu, May 16, 2024 · 8:30 AM ET | Replay |
| American Oncology Network (OTC:AONC) Q4 2023 Earnings Call | Thu, Mar 28, 2024 · 8:30 AM ET | Replay |
| American Oncology Network (OTC:AONC) Q3 2023 Earnings Call | Tue, Nov 14, 2023 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | Mar 27, 2025 | −5.3% |
| Q4 2022 | Mar 31, 2023 | +0.7% |
| Q3 2022 | Nov 14, 2022 | −0.2% |
| Q2 2022 | Aug 12, 2022 | +0.1% |
| Q1 2022 | Apr 13, 2022 | +0.2% |
| Q3 2021 | Nov 22, 2021 | +0.6% |
| Q2 2021 | Aug 24, 2021 | |
| Q1 2021 | May 27, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2023) | Investor deck | 29 slides | Sep 29, 2023 |
| Digital Transformation Opportunities — SPAC Merger (October 2022) | SPAC merger | 26 slides | Oct 6, 2022 |
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.76B | 1.28B | 1.15B | 943.7M | 724.7M | |
| Cost of revenue | 1.64B | 1.20B | 1.05B | 865.8M | 658.6M | |
| Gross profit | 117.8M | 82.8M | 95.5M | 78.0M | 66.1M | |
| Selling, general and administrative | 133.9M | 100.7M | 86.6M | 77.0M | 44.0M | |
| Operating income | -17.4M | -49.2M | 5.57M | 911.0K | 22.1M | |
| Depreciation and amortization | 19.4M | 16.7M | 17.1M | 6.08M | 3.66M | 1.01M |
| EBITDA | 1.94M | -32.4M | 22.6M | 6.99M | 25.7M | |
| Interest expense | 7.06M | 6.42M | 3.42M | 1.42M | 1.12M | |
| Income before tax | -24.5M | -62.5M | 2.59M | 355.0K | 21.2M | |
| Income tax | 2.50M | 384.0K | 1.03B | 460.0K | -783.0K | -245.0K |
| Net income | -3.97M | -5.54M | 2.59M | -105.0K | 22.0M | |
| Earnings per share, basic | -0.29 | -0.83 | 0.06 | -0.00 | 0.74 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash and equivalents | 62.8M | 28.5M | 26.9M | 27.4M | 25.0K |
| Short-term investments | 9.79M | 35.4M | 9.85M | 0 | |
| Receivables | 189.6M | 165.0M | 166.1M | 138.1M | 97.9M |
| Inventory | 60.7M | 44.6M | 36.5M | 34.5M | 22.1M |
| Current assets | 331.5M | 277.8M | 242.0M | 208.3M | 25.0K |
| Property, plant and equipment | 75.7M | 32.6M | 28.7M | ||
| Goodwill | 10.9M | 1.05M | |||
| Total assets | 470.3M | 374.5M | 326.2M | 248.3M | 49.0K |
| Accounts payable | 170.7M | 127.6M | 106.5M | 92.9M | 70.3M |
| Current liabilities | 216.8M | 169.0M | 140.9M | 119.3M | 24.9K |
| Long-term debt | 87.1M | 80.6M | 80.3M | 63.7M | |
| Total debt | 147.4M | 128.3M | 127.1M | 63.7M | |
| Total liabilities | 362.3M | 303.7M | 264.2M | 22.3M | 24.9K |
| Shareholders' equity | 18.8M | -161.7M | 62.0M | 312.6M | 24.2K |
| Shares outstanding | 13.5M | 6.69M | 41.7M | 41.7M | 29.9M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash from operations | -4.94M | -18.1M | -6.78M | -1.23M | 37.2M | -18.3M |
| Capital spending | -21.0M | -12.3M | -7.19M | -8.32M | -12.2M | -11.6M |
| Free cash flow | -25.9M | -30.4M | -14.0M | -34.7M | 25.0M | -29.9M |
| Cash from investing | -2.41M | -35.4M | -14.0M | -333.5M | -14.7M | -21.2M |
| Cash from financing | 41.7M | 55.1M | 15.3M | 335.5M | 16.3M | 39.2M |
| Share buybacks | -368.0K | -9.57M | 0 | 0 | ||
| Change in cash | 34.3M | 1.61M | -5.43M | 803.3K | 38.8M | -329.0K |
Cap table
Built by 6ix from American Oncology Network, Inc.’s releases
- Common shares
- 29,248,362
- Fully diluted
- 29,248,362
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 29,248,362 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 29,248,362 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bradley M. Fluegel Other companies: Performant Financial Corporation (Director · Since at least Feb 4, 2014); NeuroMetrix Inc (Director · Jul 1, 2022 – May 22, 2024 · Past); Digital Transformation Opportunities Corp (Director · Mar 9, 2021 – Mar 9, 2021 · Past); Fitbit Inc (Director · Mar 4, 2018 – Jan 14, 2021 · Past); Walgreen Company (Senior Vice President · Oct 1, 2012 – Nov 1, 2014 · Past); Elevance Health, Inc. (EVP, Chief Strategy Officer · Nov 1, 2010 – Nov 5, 2010 · Past) | BOARD MEMBER · Since at least Sep 20, 2023 |
| Ravi Sarin Other companies: The Oncology Institute, Inc. (Director · Nov 12, 2021 – Mar 17, 2023 · Past) | BOARD MEMBER · Since at least Sep 20, 2023 |
| William Bill J. Valle Other companies: TriSalus Life Sciences, Inc. (Director · Since at least Jan 29, 2025) | BOARD MEMBER · Since at least Apr 19, 2024 |
| Alti Rahman | CHIEF STRATEGY & INNOVATION OFFICER · Since at least Nov 5, 2026 |
| Anthony Belott | CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026 |
| Antonio Moran | BOARD MEMBER · Since at least Nov 4, 2026 |
| Asit Jha | BOARD MEMBER · Since at least Nov 4, 2026 |
| Bradley T. Sumrall | BOARD MEMBER · Since at least Nov 4, 2026 |
| Charles Charlie Goddard | GENERAL COUNSEL · Since at least Nov 5, 2026 |
| Christopher Chay | BOARD MEMBER · Since at least Nov 4, 2026 |
All 46 people
| Person | Seat |
|---|---|
| Daniel Spitz | BOARD MEMBER · Since at least Nov 4, 2026 |
| Daniel T. Milton | BOARD MEMBER · Since at least Nov 4, 2026 |
| David Afshar | CHIEF FINANCIAL & OPERATING OFFICER · Since at least Nov 5, 2026 |
| David H Gould | Chief Financial Officer · Sep 20, 2023 – Sep 20, 2023 · Past |
| Ella S. Friedman | PRESIDENT NETWORK OPERATIONS · Since at least Nov 5, 2026 |
| Erica Mallon | General Counsel · Sep 20, 2023 – Jul 16, 2024 · Past |
| Farn Chan | BOARD MEMBER · Since at least Nov 4, 2026 |
| James Gilmore | CHIEF PHARMACY & CLINICAL SERVICES OFFICER · Since at least Nov 5, 2026 |
| James Stith | BOARD MEMBER · Since at least Nov 5, 2026 |
| Jay Sidloski | BOARD MEMBER · Since at least Nov 4, 2026 |
| Jeanna L. Knoble | BOARD MEMBER · Since at least Nov 4, 2026 |
| Jiantao Ding | BOARD MEMBER · Since at least Nov 4, 2026 |
| Joe Verschleiser | CHIEF GROWTH & PERFORMANCE OFFICER · Since at least Nov 4, 2026 |
| Jose Alemar | BOARD MEMBER · Since at least Nov 4, 2026 |
| Joseph Z. Ye | BOARD MEMBER · Since at least Nov 4, 2026 |
| Karen Pilley | CHIEF REVENUE CYCLE OFFICER · Since at least Nov 5, 2026 |
| Kristin Matisziw | CHIEF COMPLIANCE & RISK OFFICER · Since at least Nov 5, 2026 |
| Luis T. Campos | BOARD MEMBER · Since at least Nov 4, 2026 |
| Mark Moch | CHIEF INFORMATION OFFICER · Since at least Nov 5, 2026 |
| Martin Palmeri | BOARD MEMBER · Since at least Nov 4, 2026 |
| Michael J. Castine | BOARD MEMBER · Since at least Nov 4, 2026 |
| Praveen Kollipara | BOARD MEMBER · Since at least Nov 4, 2026 |
| Puneeth Indurlal | EXECUTIVE VICE PRESIDENT OF STRATEGIC OPERATIONS & ENTERPRISE SOLUTIONS · Since at least Nov 5, 2026 |
| Raja S. Mehdi | BOARD MEMBER · Since at least Nov 4, 2026 |
| Ralph V. Boccia | BOARD MEMBER · Since at least Nov 4, 2026 |
| Ram S. Trehan | BOARD MEMBER · Since at least Nov 4, 2026 |
| Rangappa Rajendra | BOARD MEMBER · Since at least Nov 4, 2026 |
| Sakeer Hussain | BOARD MEMBER · Since at least Nov 4, 2026 |
| Sam Mikhail | BOARD MEMBER · Since at least Nov 4, 2026 |
| Sreekanth C. Reddy | BOARD MEMBER · Since at least Nov 4, 2026 |
| Stephen Fred Divers | CHIEF MEDICAL OFFICER · Since at least Nov 4, 2026 |
| Steve Swart | EXECUTIVE VICE PRESIDENT PRACTICE OPERATIONS · Since at least Nov 4, 2026 |
| Taral Patel | BOARD MEMBER · Since at least Nov 4, 2026 |
| Tena Messer | CHIEF CLINICAL OFFICER · Since at least Nov 5, 2026 |
| Terri Casey | CHIEF HUMAN RESOURCES OFFICER · Since at least Nov 5, 2026 |
| Todd Schonherz | CHIEF EXECUTIVE OFFICER · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about American Oncology Network, Inc.